Structure Therapeutics Inc. GPCR
Set alert
20.47 USD -1.40 -6.40%
At close · Nov 2
20.47 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
20.42 Day range 22.05
20.47 52-week range 93.79
- YTD
- -70.57%
- 1 year
- -38.57%
- Open
- 21.57
- Prev close
- 21.87
- Mkt cap
- 1.46B
- Vol
- 788.35K
- Avg vol
- 1.10M
- EPS
- -3.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.42
- High
- 22.05
- Forward P/E
- -9.69
- Beta
- -1.20
- Short ratio
- 4.76
- Inst. own
- 97.61%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 33.44
- 200-d avg
- 49.06
- 1y target
- 107.29
Financial health
Altman Z-Score
10.35 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -29.0×
FY 2020 5y median -18.1× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 2.7×
FY 2020 5y median 1.7× FY 2025
P/FCF -18.2×
FY 2020 5y median -18.3× FY 2025
EV/EBITDA -23.9×
FY 2020 5y median -18.1× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -5.5%
FY 2020 5y median -5.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -9.3%
FY 2020 5y median -9.3% FY 2025
ROIC -18.9%
FY 2020 5y median -22.4% FY 2025
ROA -8.9%
FY 2020 5y median -18.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -81.7%
FY 2020 FY 2025
EPS (diluted) -2.6%
FY 2020 FY 2025
Free Cash Flow -91.5%
FY 2020 FY 2025
Financial Health
Current Ratio 24.8×
FY 2020 5y median 19.1× FY 2025
Quick Ratio 24.8×
FY 2020 5y median 19.1× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 5.7×
FY 2020 5y median 1.6× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
